logo
Select company
Select metric
71.96%Debt to Assets Ratio
VS
Market
8
Sector
9
Industry
8
History
8
$ 27.8Close
$ 13.49 - $ 27.89 52-Week Range
Ticker Information

Ticker

TVTX

Company Name

TRAVERE THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TRAVERE THERAPEUTICS INC - Debt to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TVTX - Debt to Assets Historical data
DateTotal AssetsTotal DebtDebt to Assets Ratio
6/30/2025$ 555.31M$ 399.57M71.96%
3/31/2025$ 548.8M$ 400.46M72.97%
12/31/2024$ 594.13M$ 401.58M67.59%
9/30/2024$ 504.41M$ 402.43M79.78%
6/30/2024$ 551.12M$ 403.23M73.16%
3/31/2024$ 663.55M$ 404.02M60.89%
12/31/2023$ 788.91M$ 404.78M51.31%
9/30/2023$ 832.85M$ 405.48M48.69%
6/30/2023$ 736.43M$ 406.17M55.15%
3/31/2023$ 808.23M$ 406.85M50.34%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TRAVERE THERAPEUTICS INC's latest trailing twelve months (TTM) Debt to Assets stands at 30.72%.
  • Over the past 5 years, TRAVERE THERAPEUTICS INC's average Debt to Assets has been 51.86%.
  • The median Debt to Assets for TRAVERE THERAPEUTICS INC during this period was 51.84%
  • TRAVERE THERAPEUTICS INC reached its highest Debt to Assets over the past 5 years at 79.78%.
  • The lowest Debt to Assets recorded by TRAVERE THERAPEUTICS INC in the same timeframe 28.54%

TRAVERE THERAPEUTICS INC's Debt to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Debt to Assets Benchmarks
CompanyDebt to Assets
IMCR : IMMUNOCORE HOLDINGS PLC 40.32%TARS : TARSUS PHARMACEUTICALS INC 14.57%INVA : INNOVIVA INC 33.66%VCEL : VERICEL CORP 22.9%MNKD : MANNKIND CORP 69.89%ARQT : ARCUTIS BIOTHERAPEUTICS INC 31.26%AUPH : AURINIA PHARMACEUTICALS INC 16.28%MDXG : MIMEDX GROUP INC 6.34%ARDX : ARDELYX INC 44.27%ADPT : ADAPTIVE BIOTECHNOLOGIES CORP 43.88%

Definition of Debt to Assets Ratio

[Calculation] Debt to Assets measures the ratio between a company’s [Liabilities] and [Assets]. A high ratio might indicate more risk.
Debt / Assets
(=) Debt to Assets
Debt to Assets for TRAVERE THERAPEUTICS INC is calculated as follows: Debt [ $ 212.65M ] / Assets [ $ 692.22M ]
(=) Debt to Assets [ 30.72% ]

TVTX - Debt to Assets Ratio, Last 5 years

28.54%

Minimum

Mar 31, 2021

79.78%

Maximum

Sep 30, 2024

51.86%

Average

51.84%

Median

Debt to Assets Benchmark Analysis

The chart above depicts the distribution of Debt to Assets for companies in the Total Stock Market. The average Debt to Assets of the companies is 26.32% with a standard deviation of 24.51%.
The following table provides additional summary stats:
Debt to Assets in the Market:
filtered constituents4.38K
min0%
max116.6%
average26.32%
median21.04%
std24.51%